Mr. Healy is a Vice President at RoundTable, working with the Pharmaceuticals & Consumer Health team. In this role, he focuses on the identification, evaluation, and execution of new platform investments and portfolio company add-on transactions.
Mr. Healy currently works with RoundTable’s investments in Revision Skincare / Goodier Cosmetics and Renaissance. He has also supported the firm’s investments in Santa Cruz Nutritionals, Symmetry Surgical, and SunMed.
Before joining RoundTable, Mr. Healy was an Analyst in the Global Industrials Group at Deutsche Bank Securities.
- Vice President, RoundTable, July 2020 – Present
- Senior Associate, RoundTable, July 2019 – July 2020
- Associate, RoundTable, July 2017 – July 2019
- Investment Banking Analyst, Deutsche Bank, July 2014 – April 2017
- Bachelor of Arts in Economics, Vanderbilt University, Magna Cum Laude, 2014